Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Paramo, J.A. (José Antonio) | - |
| dc.date.accessioned | 2012-06-21T17:55:30Z | - |
| dc.date.available | 2012-06-21T17:55:30Z | - |
| dc.date.issued | 2001 | - |
| dc.identifier.citation | Paramo J. Avances en el tratamiento antitrombotico. An Sist Sanit Navar 2001 Jan-Apr;24(1):39-49. | es_ES |
| dc.identifier.issn | 1137-6627 | - |
| dc.identifier.uri | https://hdl.handle.net/10171/22671 | - |
| dc.description.abstract | Improved understanding of the mechanisms of thrombogenesis has led to the discovery of new antithrombotic agents, anticoagulants, antiplatelets and fibrinolytics. Although most of them are still under development, low molecular weight heparins, glycoprotein IIb/IIIa receptor antagonists, inhibitors of the ADP receptor of platelets and new fibrinolytics have already proved their efficacy in the clinical setting. Compounds are being developed that have the potential to prevent and treat thrombosis by modulating vessel wall function | es_ES |
| dc.language.iso | spa | es_ES |
| dc.publisher | Gobierno de Navarra. Departamento de Salud | es_ES |
| dc.rights | info:eu-repo/semantics/openAccess | es_ES |
| dc.subject | Anti-thrombotic | es_ES |
| dc.subject | Therapy | es_ES |
| dc.title | Avances en el tratamiento antitrombotico | es_ES |
| dc.title.alternative | Advances in anti-thrombotic therapy | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.relation.publisherversion | http://www.cfnavarra.es/salud/anales/textos/vol24/n1/revis1a.html | es_ES |
| dc.type.driver | info:eu-repo/semantics/article | es_ES |
| dc.identifier.pmid | 12876599 | - |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.
